Youssef Daali - Search Results

Year	Number of Results
2004	2
2007	1
2008	1
2009	3
2010	3
2011	6
2012	9
2013	9
2014	8
2015	7
2016	14
2017	9
2018	8
2019	12
2020	17
2021	17
2022	15
2023	11
2024	2

1

Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping.

Abouir K, Samer C, Landry R, Varesio E, Daali Y. Abouir K, et al. Among authors: daali y. J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Jan 1;1232:123962. doi: 10.1016/j.jchromb.2023.123962. Epub 2023 Dec 9. J Chromatogr B Analyt Technol Biomed Life Sci. 2024. PMID: 38096743 Free article.

2

Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.

Ben Hassine K, Seydoux C, Khier S, Daali Y, Medinger M, Halter J, Heim D, Chalandon Y, Schanz U, Nair G, Cantoni N, Passweg JR, Satyanarayana Uppugunduri CR, Ansari M. Ben Hassine K, et al. Among authors: daali y. Transplant Cell Ther. 2024 Mar;30(3):332.e1-332.e15. doi: 10.1016/j.jtct.2023.12.003. Epub 2023 Dec 9. Transplant Cell Ther. 2024. PMID: 38081414 Free article.

3

Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.

Terrier J, Gaspar F, Gosselin P, Raboud O, Lenoir C, Rollason V, Csajka C, Samer C, Fontana P, Daali Y, Reny JL; OptimAT study group. Terrier J, et al. Among authors: daali y. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1872-1883. doi: 10.1002/psp4.13036. Epub 2023 Oct 4. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37794718 Free PMC article.

4

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol.

Rodieux F, Storelli F, Curtin F, Manzano S, Gervaix A, Posfay-Barbe KM, Desmeules J, Daali Y, Samer CF. Rodieux F, et al. Among authors: daali y. Pharmaceuticals (Basel). 2023 Aug 30;16(9):1227. doi: 10.3390/ph16091227. Pharmaceuticals (Basel). 2023. PMID: 37765034 Free PMC article.

5

Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.

Gaspar F, Terrier J, Favre S, Gosselin P, Fontana P, Daali Y, Lenoir C, Samer CF, Rollason V, Reny JL, Csajka C, Guidi M. Gaspar F, et al. Among authors: daali y. CPT Pharmacometrics Syst Pharmacol. 2023 Oct;12(10):1541-1552. doi: 10.1002/psp4.13032. Epub 2023 Sep 18. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37723920 Free PMC article.

6

Impact of Obesity and Bariatric Surgery on Metabolic Enzymes and P-Glycoprotein Activity Using the Geneva Cocktail Approach.

Ghasim H, Rouini M, Safari S, Larti F, Khoshayand M, Gholami K, Neyshaburinezhad N, Gloor Y, Daali Y, Ardakani YH. Ghasim H, et al. Among authors: daali y. J Pers Med. 2023 Jun 25;13(7):1042. doi: 10.3390/jpm13071042. J Pers Med. 2023. PMID: 37511655 Free PMC article.

7

Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol.

Bianchi F, Pautex S, Wampfler J, Curtin F, Daali Y, Desmeules JA, Broers B. Bianchi F, et al. Among authors: daali y. Front Pain Res (Lausanne). 2023 May 24;4:1108832. doi: 10.3389/fpain.2023.1108832. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37293434 Free PMC article.

8

Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs.

Darnaud L, Delage C, Daali Y, Trouvin AP, Perrot S, Khoudour N, Merise N, Labat L, Etain B, Bellivier F, Lloret-Linares C, Bloch V, Curis E, Declèves X. Darnaud L, et al. Among authors: daali y. Pharmaceutics. 2023 Mar 18;15(3):979. doi: 10.3390/pharmaceutics15030979. Pharmaceutics. 2023. PMID: 36986840 Free PMC article.

9

Practice of CYP450 genotyping and phenotyping in children in a real-life setting.

Rodieux F, Daali Y, Rollason V, Samer CF, Ing Lorenzini K. Rodieux F, et al. Among authors: daali y. Front Pharmacol. 2023 Feb 27;14:1130100. doi: 10.3389/fphar.2023.1130100. eCollection 2023. Front Pharmacol. 2023. PMID: 36937881 Free PMC article.

10

Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail.

Neyshaburinezhad N, Shirzad N, Rouini M, Namazi S, Khoshayand M, Esteghamati A, Nakhjavani M, Ghasim H, Gloor Y, Daali Y, Ardakani YH. Neyshaburinezhad N, et al. Among authors: daali y. Basic Clin Pharmacol Toxicol. 2023 Jun;132(6):487-499. doi: 10.1111/bcpt.13840. Epub 2023 Mar 21. Basic Clin Pharmacol Toxicol. 2023. PMID: 36734157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year